Catalyst Wire Dossier Catalyst Wire Dossier

SNA02-48 Injection

SNA02-48 · Sinovac Life Sciences Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SNA02-48 Injection, covering 2025-04-25 to 2025-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants [Phase 1, Phase 2]

See pricing